文献速递神经儿科影像MR

高级ADC直方图、灌注及渗透性指标与初诊弥漫性内生性脑桥胶质瘤生存及假性进展相关:来自儿童脑肿瘤联盟的报告

Advanced ADC Histogram, Perfusion, and Permeability Metrics Show an Association with Survival and Pseudoprogression in Newly Diagnosed Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium.
PubMed 文献 · AJNR Am J Neuroradiol · 2020-04-02

本研究基于儿童脑肿瘤联盟的临床试验,对50例可评估初诊弥漫性内生性脑桥胶质瘤患儿在基线及治疗期间行标准MRI、DWI、动态增强灌注和DSC灌注,分析ADC直方图、渗透性及相对CBV指标与生存和假性进展的关系,发现较高基线相对CBV及随时间增加与更短生存相关,真性进展较假性进展放疗后FLAIR mode_ADC下降更明显。

要点

  • 较高基线相对CBV与更短无进展生存(P=0.02,Q=0.089)和总生存(P=0.006,Q=0.055)相关。
  • 相对CBV随时间增加与更短无进展生存(P<0.001,Q<0.001)和总生存(P=0.004,Q=0.043)相关。
  • 真性进展较假性进展放疗后FLAIR mode_ADC下降更明显(均值-268.15 vs -26.11,P=0.01)。

诊断标准与关键数值

  • 较高基线相对CBV与更短无进展生存相关(P=0.02,Q=0.089)及更短总生存相关(P=0.006,Q=0.055)。
  • 较高基线mean transfer constant from blood plasma into extravascular extracellular space与更短无进展生存(P=0.03,Q=0.105)和总生存(P=0.03,Q=0.102)的相关性趋势接近显著。
  • 相对CBV随时间增加与更短无进展生存(P<0.001,Q<0.001)和总生存(P=0.004,Q=0.043)相关。
  • 纵向mean extravascular extracellular volume fraction与无进展生存(P=0.03,Q=0.104)和总生存(P=0.03,Q=0.105)及maximum transfer constant from blood plasma into extravascular extracellular space与无进展生存(P=0.03,Q=0.102)的相关性趋势接近显著,随时间增加越大结局越差。
  • 真性影像学进展较假性进展放疗后FLAIR mode_ADC下降更明显(均值-268.15 vs -26.11,P=0.01)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Diffuse intrinsic pontine glioma is a lethal childhood brain cancer with dismal prognosis and MR imaging is the primary methodology used for diagnosis and monitoring. Our aim was to determine whether advanced diffusion, perfusion, and permeability MR imaging metrics predict survival and pseudoprogression in children with newly diagnosed diffuse intrinsic pontine glioma.

MATERIALS AND METHODS: A clinical trial using the poly (adenosine diphosphate ribose) polymerase (PARP) inhibitor veliparib concurrently with radiation therapy, followed by maintenance therapy with veliparib + temozolomide, in children with diffuse intrinsic pontine glioma was conducted by the Pediatric Brain Tumor Consortium. Standard MR imaging, DWI, dynamic contrast-enhanced perfusion, and DSC perfusion were performed at baseline and approximately every 2 months throughout treatment. ADC histogram metrics of T2-weighted FLAIR and enhancing tumor volume, dynamic contrast-enhanced permeability metrics for enhancing tumors, and tumor relative CBV from DSC perfusion MR imaging were calculated. Baseline values, post-radiation therapy changes, and longitudinal trends for all metrics were evaluated for associations with survival and pseudoprogression.

RESULTS: Fifty children were evaluable for survival analyses. Higher baseline relative CBV was associated with shorter progression-free survival (P = .02, Q = 0.089) and overall survival (P = .006, Q = 0.055). Associations of higher baseline mean transfer constant from the blood plasma into the extravascular extracellular space with shorter progression-free survival (P = .03, Q = 0.105) and overall survival (P = .03, Q = 0.102) trended toward significance. An increase in relative CBV with time was associated with shorter progression-free survival (P < .001, Q < 0.001) and overall survival (P = .004, Q = 0.043). Associations of longitudinal mean extravascular extracellular volume fraction with progression-free survival (P = .03, Q = 0.104) and overall survival (P = .03, Q = 0.105) and maximum transfer constant from the blood plasma into the extravascular extracellular space with progression-free survival (P = .03, Q = 0.102) trended toward significance. Greater increases with time were associated with worse outcomes. True radiologic progression showed greater post-radiation therapy decreases in mode_ADC_FLAIR compared with pseudoprogression (means, -268.15 versus -26.11, P = .01.) CONCLUSIONS: ADC histogram, perfusion, and permeability MR imaging metrics in diffuse intrinsic pontine glioma are useful in predicting survival and pseudoprogression.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Vajapeyam S, Brown D, Billups C, et al. Advanced ADC Histogram, Perfusion, and Permeability Metrics Show an Association with Survival and Pseudoprogression in Newly Diagnosed Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium. AJNR Am J Neuroradiol. 2020. PMID: 32241771. doi:10.3174/ajnr.A6499

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。